Watson launches Generess Fe low-dose oral contraceptives in the U.S.

[News]

Watson Pharmaceuticals, Inc., today announced the U.S. commercial launch of Generess Fe 0.8 mg/25 mcg, a new low-dose oral contraceptive option that's highly effective at preventing pregnancy and proven to provide users with short, lighter, predictable periods.

More... (http://www.news-medical.net/news/20110502/Watson-launches-Generess-Fe-low-dose-oral-contraceptives-in-the-US.aspx)